{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:25:52Z","timestamp":1793258752834,"version":"4.5.0"},"reference-count":188,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100023296","name":"Alleanza Contro il Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023296","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jacc.2025.02.001","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T23:57:43Z","timestamp":1746057463000},"page":"2504-2535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["2025 AHA\/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease"],"prefix":"10.1016","volume":"85","author":[{"given":"Marlene S.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn N.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anandita","family":"Agarwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Baptiste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin E.","family":"Cigarroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Diekemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marva V.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipti","family":"Itchhaporia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Lawton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Kristin","family":"Newby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly C.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishan","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline E.","family":"Tamis-Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2025.02.001_bib1","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.jacc.2010.09.009","article-title":"ACCF\/AHA new insights into the methodology of performance measurement: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Performance Measures","volume":"56","author":"Spertus","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jacc.2005.03.011","article-title":"American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care","volume":"45","author":"Spertus","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jacc.2011.05.002","volume":"58","author":"Drozda","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib4","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jacc.2023.04.003","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"82","author":"Virani","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib5","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.jacc.2014.03.016","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines","volume":"63","author":"Anderson","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib7","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.amepre.2023.11.009","article-title":"Trends in cardiovascular disease mortality rates and excess deaths, 2010-2022","volume":"66","author":"Woodruff","year":"2024","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib8","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1161\/CIR.0000000000000534","article-title":"Cardiovascular health in African Americans: a scientific statement from the American Heart Association","volume":"136","author":"Carnethon","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022817","article-title":"Equity in heart transplant allocation: intended progress up the hill or an impossibility?","volume":"10","author":"Lewsey","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.02.001_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s41649-020-00145-z","article-title":"The pitfalls of overtreatment: why more care is not necessarily beneficial","volume":"12","author":"Ooi","year":"2020","journal-title":"Asian Bioeth Rev"},{"key":"10.1016\/j.jacc.2025.02.001_bib11","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1001\/jama.2018.2202","article-title":"Choosing wisely campaigns: a work in progress","volume":"319","author":"Levinson","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.02.001_bib12","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12961-022-00815-4","article-title":"Strategies for the implementation of clinical practice guidelines in public health: an overview of systematic reviews","volume":"20","author":"Pereira","year":"2022","journal-title":"Health Res Policy Syst"},{"key":"10.1016\/j.jacc.2025.02.001_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12961-022-00865-8","article-title":"Strategies to adapt and implement health system guidelines and recommendations: a scoping review","volume":"20","author":"Breneol","year":"2022","journal-title":"Health Res Policy Syst"},{"key":"10.1016\/j.jacc.2025.02.001_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/healthcare4030036","article-title":"Barriers and strategies in guideline implementation-a scoping review","volume":"4","author":"Fischer","year":"2016","journal-title":"Healthcare"},{"key":"10.1016\/j.jacc.2025.02.001_bib16","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.jacc.2023.03.409","article-title":"2023 AHA\/ACC clinical performance and quality measures for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Performance Measures","volume":"82","author":"Dehmer","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib17","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/j.jacc.2019.10.001","article-title":"2019 AHA\/ACC clinical performance and quality measures for adults with high blood pressure: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures","volume":"74","author":"Casey","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/intqhc\/10.3.247","article-title":"Eliciting expert opinion using the Delphi technique: identifying performance indicators for cardiovascular disease","volume":"10","author":"Normand","year":"1998","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.jacc.2025.02.001_bib19","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.jacc.2018.01.004","article-title":"2018 ACC\/AHA clinical performance and quality measures for cardiac rehabilitation: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures","volume":"71","author":"Thomas","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib21","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 Heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2020.25019","article-title":"Interventions for tobacco smoking cessation in adults, including pregnant persons: US Preventive Services Task Force recommendation statement","volume":"325","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.02.001_bib24","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1016\/j.jacc.2018.10.027","article-title":"2018 ACC expert consensus decision pathway on tobacco cessation treatment: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents","volume":"72","author":"Barua","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jacc.2025.02.001_bib25","first-page":"CD000165","article-title":"Physician advice for smoking cessation","volume":"2013","author":"Stead","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.02.001_bib26","article-title":"Behavioural interventions for smoking cessation: an overview and network meta-analysis","volume":"1","author":"Hartmann-Boyce","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jacc.2025.02.001_bib27","first-page":"CD013308","article-title":"Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation","volume":"4","author":"Lindson","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.02.001_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.115.002458","article-title":"Efficacy and safety of smoking cessation interventions in patients with cardiovascular disease: a network meta-analysis of randomized controlled trials","volume":"10","author":"Suissa","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2025.02.001_bib29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.02.001_bib30","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.02.001_bib31","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/S0140-6736(21)01063-1","article-title":"Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial","volume":"397","author":"Koo","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.02.001_bib32","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/jama.2019.8145","article-title":"Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial","volume":"321","author":"Watanabe","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.02.001_bib33","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib34","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2102137","article-title":"Comparative effectiveness of aspirin dosing in cardiovascular disease","volume":"384","author":"Jones","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib35","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"68","author":"Levine","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib36","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMra1806939","article-title":"Lipid management for the prevention of atherosclerotic cardiovascular disease","volume":"381","author":"Michos","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib37","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","article-title":"Life's essential 8: updating and enhancing the American Heart Association's construct of cardiovascular health: a presidential advisory from the American Heart Association","volume":"146","author":"Lloyd-Jones","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2022.100335","article-title":"Atherosclerotic cardiovascular disease risk assessment: an American Society for Preventive Cardiology clinical practice statement","volume":"10","author":"Wong","year":"2022","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib39","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.02.001_bib40","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.amjcard.2019.12.030","article-title":"Impact of lipid monitoring on treatment intensification of cholesterol lowering therapies (from the Veterans Affairs Healthcare System)","volume":"125","author":"Jia","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib41","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/ehjcvp\/pvw006","article-title":"Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER","volume":"2","author":"Karlson","year":"2016","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacc.2025.02.001_bib42","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.amjmed.2021.11.011","article-title":"Association of low-density lipoprotein testing after an atherosclerotic cardiovascular event with subsequent statin adherence and intensification","volume":"135","author":"Rana","year":"2022","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(18)31942-1","article-title":"Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials","volume":"393","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.02.001_bib44","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib45","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/HYPERTENSIONAHA.117.10786","article-title":"Hypertension, microvascular pathology, and prognosis after an acute myocardial infarction","volume":"72","author":"Carrick","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.02.001_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019017","article-title":"One-year landmark analysis of the effect of beta-blocker dose on survival after acute myocardial infarction","volume":"10","author":"Goldberger","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.02.001_bib47","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib48","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Sprint Research Group","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib49","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/eurheartj\/ehz149","article-title":"Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk","volume":"40","author":"Bohm","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.02.001_bib50","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jamacardio.2017.1421","article-title":"Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis","volume":"2","author":"Bundy","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib51","doi-asserted-by":"crossref","first-page":"895","DOI":"10.7326\/M20-2037","article-title":"Effect of intensive blood pressure lowering on cardiovascular outcomes: a systematic review prepared for the 2020 U.S. Department of Veterans Affairs\/U.S. Department of Defense Guidelines","volume":"173","author":"D'Anci","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib52","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/jch.13581","article-title":"Determination of optimal on-treatment diastolic blood pressure range using automated measurements in subjects with cardiovascular disease\u2014analysis of a SPRINT trial subpopulation","volume":"21","author":"Sobieraj","year":"2019","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacc.2025.02.001_bib53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"issue":"suppl J","key":"10.1016\/j.jacc.2025.02.001_bib54","first-page":"J52","article-title":"The European trial on reduction of cardiac events with perindopril in stable coronary artery disease (EUROPA)","volume":"19","author":"Fox","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.02.001_bib55","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jacc.2011.01.008","article-title":"ACCF\/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.","volume":"57","author":"Aronow","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib56","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/hrt.38.2.155","article-title":"Effects of the cardioselective beta-adrenergic receptor blocking agent metoprolol in angina pectoris. Subacute study with exercise tests","volume":"38","author":"Ekelund","year":"1976","journal-title":"Br Heart J"},{"key":"10.1016\/j.jacc.2025.02.001_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.02.001_bib58","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/HYP.0000000000000018","article-title":"Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension","volume":"65","author":"Rosendorff","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.02.001_bib59","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.jacc.2011.10.824","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation","volume":"58","author":"Smith","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib60","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(04)16980-8","article-title":"Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial","volume":"364","author":"Poole-Wilson","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.02.001_bib61","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.02.001_bib62","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/ehjcvp\/pvaa029","article-title":"Effect of beta-blocker therapy in patients with or without left ventricular systolic dysfunction after acute myocardial infarction","volume":"7","author":"Joo","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacc.2025.02.001_bib63","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","article-title":"Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib64","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.02.001_bib65","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib66","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/01.CIR.92.2.212","article-title":"Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease","volume":"92","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib67","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJM200105313442202","article-title":"A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure","volume":"344","author":"Eichhorn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib68","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib69","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.010159","article-title":"Left ventricular ejection fraction 1 year after acute myocardial infarction identifies the benefits of the long-term use of beta-blockers: analysis of data from the KAMIR-NIH registry","volume":"14","author":"Park","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2025.02.001_bib70","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCOUTCOMES.114.001073","article-title":"Beta-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial","volume":"7","author":"Bangalore","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2025.02.001_bib71","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0735-1097(96)00489-5","article-title":"Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators","volume":"29","author":"Vantrimpont","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib72","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.02.001_bib73","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"ACE-Inhibitor Myocardial Infarction Collaborative Group. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.02.001_bib74","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction","volume":"333","author":"K\u00f8ber","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib75","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.292.18.2217","article-title":"Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure. The CAMELOT study: a randomized controlled trial","volume":"292","author":"Nissen","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.02.001_bib76","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib77","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","author":"Yusuf","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib78","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1056\/NEJMoa053107","article-title":"Efficacy and safety of benazepril for advanced chronic renal insufficiency","volume":"354","author":"Hou","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib79","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/jama.2019.12843","article-title":"Effect of sacubitril-valsartan vs enalapril on aortic stiffness in patients with heart failure and reduced ejection fraction: a randomized clinical trial","volume":"322","author":"Desai","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.02.001_bib80","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib81","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin\u2013neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib82","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/ejhf.1498","article-title":"Initiation of sacubitril\/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study","volume":"21","author":"Wachter","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.02.001_bib83","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012272","article-title":"Effects of the angiotensin-receptor neprilysin inhibitor on cardiac reverse remodeling: meta-analysis","volume":"8","author":"Wang","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"19","key":"10.1016\/j.jacc.2025.02.001_bib84","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.jacc.2024.06.013","article-title":"2024 AHA\/ACC\/ACS\/ASNC\/HRS\/SCA\/SCCT\/SCMR\/SVM guideline for perioperative cardiovascular management for noncardiac surgery: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"84","author":"Thompson","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib85","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMoa2208335","article-title":"Routine functional testing or standard care in high-risk patients after PCI","volume":"387","author":"Park","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib86","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jacc.2023.12.027","article-title":"Surveillance stress testing after percutaneous intervention for patients with multivessel or left main coronary disease","volume":"83","author":"Lee","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib87","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jcin.2016.10.018","article-title":"The ReACT Trial: Randomized Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial","volume":"10","author":"Shiomi","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2025.02.001_bib88","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib89","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib90","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa1505532","article-title":"Effect of PCI on long-term survival in patients with stable ischemic heart disease","volume":"373","author":"Sedlis","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib91","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/eurheartj\/ehz660","article-title":"Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry","volume":"41","author":"Sorbets","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.02.001_bib92","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1001\/jama.2010.580","article-title":"Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005","volume":"303","author":"Wijeysundera","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.02.001_bib93","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1916374","article-title":"Health status after invasive or conservative care in coronary and advanced kidney disease","volume":"382","author":"Spertus","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib94","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.jacc.2023.03.410","article-title":"ACC\/AHA\/ASE\/ASNC\/ASPC\/HFSA\/HRS\/SCAI\/SCCT\/SCMR\/STS 2023 multimodality appropriate use criteria for the detection and risk assessment of chronic coronary disease","volume":"81","author":"Winchester","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib95","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jamainternmed.2014.3773","article-title":"Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry","volume":"174","author":"Steg","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib96","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11886-018-0957-z","article-title":"Routine angiographic follow-up after coronary artery disease revascularization: is seeing believing?","volume":"20","author":"Agrawal","year":"2018","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jacc.2025.02.001_bib97","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3904\/kjim.2015.30.1.49","article-title":"Clinical impact of routine follow-up coronary angiography after second- or third-generation drug-eluting stent insertion in clinically stable patients","volume":"30","author":"Choi","year":"2015","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib98","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016169","article-title":"Outcome of revascularisation in stable coronary artery disease without ischaemia: a Danish registry-based follow-up study","volume":"7","author":"Simonsen","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2025.02.001_bib99","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jcin.2010.01.010","article-title":"The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of \"oculostenotic\" reintervention in patients with intermediate lesions","volume":"3","author":"Uchida","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2025.02.001_bib100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ahj.2005.03.034","article-title":"Determinants of referral to cardiac rehabilitation programs in patients with coronary artery disease: a systematic review","volume":"151","author":"Cort\u00e9s","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2025.02.001_bib101","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/CIRCULATIONAHA.109.876383","article-title":"Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly medicare beneficiaries","volume":"121","author":"Hammill","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib102","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1161\/CIRCULATIONAHA.115.018926","article-title":"Enhancing cardiac rehabilitation with stress management training: a randomized, clinical efficacy trial","volume":"133","author":"Blumenthal","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib103","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.mayocpiqo.2021.06.009","article-title":"Multicomponent cardiac rehabilitation and cardiovascular outcomes in patients with stable angina: a systematic review and meta-analysis","volume":"5","author":"Saeidifard","year":"2021","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/j.jacc.2025.02.001_bib104","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib105","first-page":"CD007130","article-title":"Home-based versus centre-based cardiac rehabilitation","volume":"6","author":"Anderson","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.02.001_bib106","first-page":"CD008895","article-title":"Patient education in the management of coronary heart disease","volume":"6","author":"Anderson","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.02.001_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2015.10.044","article-title":"Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis","volume":"67","author":"Anderson","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib108","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/2047487312462824","article-title":"Lifestyle modification programmes for patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials","volume":"20","author":"Janssen","year":"2013","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib109","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib110","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1161\/CIRCULATIONAHA.106.180945","volume":"115","author":"Balady","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib111","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1161\/hc3901.095960","article-title":"Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association","volume":"104","author":"Fletcher","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib112","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.amjmed.2004.01.009","article-title":"Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials","volume":"116","author":"Taylor","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib113","first-page":"1","article-title":"Cardiac rehabilitation as secondary prevention. Agency for Health Care Policy and Research and National Heart, Lung, and Blood Institute","author":"Wenger","year":"1995","journal-title":"Clin Pract Guidel Quick Ref Guide Clin"},{"key":"10.1016\/j.jacc.2025.02.001_bib114","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O'Gara","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib115","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.110.983536","article-title":"Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community","volume":"123","author":"Goel","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib116","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.0000151788.08740.5C","article-title":"Cardiac rehabilitation and secondary prevention of coronary heart disease","volume":"111","author":"Leon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib117","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jacc.2009.01.078","article-title":"Cardiac rehabilitation and survival in older coronary patients","volume":"54","author":"Suaya","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib118","doi-asserted-by":"crossref","first-page":"659","DOI":"10.7326\/0003-4819-143-9-200511010-00010","article-title":"Meta-analysis: secondary prevention programs for patients with coronary artery disease","volume":"143","author":"Clark","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib119","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jacc.2007.04.033","article-title":"AACVPR\/ACC\/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation\/secondary prevention services","volume":"50","author":"Thomas","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/HJR.0b013e3282f29aa6","article-title":"Regular exercise training compared with percutaneous intervention leads to a reduction of inflammatory markers and cardiovascular events in patients with coronary artery disease","volume":"15","author":"Walther","year":"2008","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.jacc.2025.02.001_bib121","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/CIR.0b013e31820faaf8","article-title":"Effectiveness-based guidelines for the prevention of cardiovascular disease in women\u20142011 update","volume":"123","author":"Mosca","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib122","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.jacc.2011.08.009","article-title":"2011 ACCF\/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines.","volume":"58","author":"Hillis","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib123","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00008483-199701000-00004","article-title":"Quality of life and return to work 5 years after coronary artery bypass surgery. Long-term results of cardiac rehabilitation","volume":"17","author":"Engblom","year":"1997","journal-title":"J Cardiopulm Rehabil"},{"key":"10.1016\/j.jacc.2025.02.001_bib124","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1378\/chest.113.3.599","article-title":"The effects of body composition changes to observed improvements in cardiopulmonary parameters after exercise training with cardiac rehabilitation","volume":"113","author":"Milani","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2025.02.001_bib125","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib126","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1001\/archinte.168.20.2194","article-title":"Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network","volume":"168","author":"Giannuzzi","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib127","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/01.ATV.0000087143.33998.F2","article-title":"Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease","volume":"23","author":"Thompson","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2025.02.001_bib128","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jacc.2004.05.062","article-title":"Cardiac rehabilitation after myocardial infarction in the community","volume":"44","author":"Witt","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib129","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.008215","article-title":"Million Hearts cardiac rehabilitation think tank: accelerating new care models","volume":"14","author":"Beatty","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2025.02.001_bib130","doi-asserted-by":"crossref","first-page":"e705","DOI":"10.1161\/CIR.0000000000000749","article-title":"Exercise-related acute cardiovascular events and potential deleterious adaptations following long-term exercise training: placing the risks into perspective-an update: a scientific statement from the American Heart Association","volume":"141","author":"Franklin","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib131","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/bjsports-2021-103994","article-title":"Risk of atrial fibrillation in athletes: a systematic review and meta-analysis","volume":"55","author":"Newman","year":"2021","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib132","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jcmg.2016.03.010","article-title":"Progression of CAC score and risk of incident CVD","volume":"9","author":"Radford","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.jacc.2025.02.001_bib133","article-title":"Exercise-based cardiac rehabilitation in heart transplant recipients","author":"Anderson","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.02.001_bib134","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/ehf2.12329","article-title":"Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients","volume":"5","author":"Asleh","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacc.2025.02.001_bib135","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/CIRCULATIONAHA.118.036747","article-title":"Effect of high-intensity interval training in de novo heart transplant recipients in Scandinavia","volume":"139","author":"Nytroen","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib136","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1111\/j.1600-6143.2012.04221.x","article-title":"High-intensity interval training improves peak oxygen uptake and muscular exercise capacity in heart transplant recipients","volume":"12","author":"Nytroen","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jacc.2025.02.001_bib137","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.healun.2013.06.023","article-title":"Effect of high-intensity interval training on progression of cardiac allograft vasculopathy","volume":"32","author":"Nytroen","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2025.02.001_bib138","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14488","article-title":"A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy","volume":"36","author":"Rafique","year":"2022","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jacc.2025.02.001_bib139","first-page":"554","article-title":"The first dedicated cardiac rehabilitation program for patients with spontaneous coronary artery dissection: description and initial results","volume":"32","author":"Chou","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib140","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1161\/CIR.0000000000000564","article-title":"Spontaneous coronary artery dissection: current state of the science: a scientific statement from the American Heart Association","volume":"137","author":"Hayes","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib141","article-title":"Safety and outcomes of cardiac rehabilitation for patients with spontaneous coronary artery dissection","volume":"1","author":"Imran","year":"2018","journal-title":"J Rehabil Med Clin Commun"},{"key":"10.1016\/j.jacc.2025.02.001_bib142","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.amjcard.2016.02.034","article-title":"Usefulness of cardiac rehabilitation after spontaneous coronary artery dissection","volume":"117","author":"Krittanawong","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib143","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/jamacardio.2017.2471","article-title":"Comparison of coronary CT angiography, SPECT, PET, and hybrid imaging for diagnosis of ischemic heart disease determined by fractional flow reserve","volume":"2","author":"Danad","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib144","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/CIRCULATIONAHA.120.049755","article-title":"Outcomes in the ISCHEMIA trial based on coronary artery disease and ischemia severity","volume":"144","author":"Reynolds","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib145","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ahj.2012.05.018","article-title":"Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention","volume":"164","author":"Shaw","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2025.02.001_bib146","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.echo.2010.05.004","article-title":"Prognostic implications of stress echocardiography and impact on patient outcomes: an effective gatekeeper for coronary angiography and revascularization","volume":"23","author":"Yao","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.jacc.2025.02.001_bib147","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.jacc.2020.07.060","article-title":"Gadobutrol-enhanced cardiac magnetic resonance imaging for detection of coronary artery disease","volume":"76","author":"Arai","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib148","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/ehjci\/jez258","article-title":"Prognostic value of [15O]H2O positron emission tomography-derived global and regional myocardial perfusion","volume":"21","author":"Bom","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2025.02.001_bib149","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2018.10.056","article-title":"Comparison of coronary computed tomography angiography, fractional flow reserve, and perfusion imaging for ischemia diagnosis","volume":"73","author":"Driessen","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib150","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/jamacardio.2019.0035","article-title":"Prognostic value of vasodilator stress cardiac magnetic resonance imaging: a multicenter study with 48000 patient-years of follow-up","volume":"4","author":"Heitner","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib151","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jacc.2017.06.028","article-title":"Stress perfusion coronary flow reserve versus cardiac magnetic resonance for known or suspected CAD","volume":"70","author":"Kato","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib152","first-page":"1282","article-title":"The prognostic significance of quantitative myocardial perfusion: an artificial intelligence-based approach using perfusion mapping","volume":"141","author":"Knott","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib153","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.jacc.2019.07.074","article-title":"Cardiac magnetic resonance stress perfusion imaging for evaluation of patients with chest pain","volume":"74","author":"Kwong","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib154","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.jacc.2019.06.074","article-title":"Ischemia on PET MPI may identify patients with improvement in angina and health status post-revascularization","volume":"74","author":"Patel","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib155","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/eurheartj\/ehz389","article-title":"Myocardial blood flow reserve assessed by positron emission tomography myocardial perfusion imaging identifies patients with a survival benefit from early revascularization","volume":"41","author":"Patel","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.02.001_bib156","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.jacc.2019.07.055","article-title":"Extent of myocardial ischemia on positron emission tomography and survival benefit with early revascularization","volume":"74","author":"Patel","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib157","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jamacardio.2020.0822","article-title":"Association of sex with severity of coronary artery disease, ischemia, and symptom burden in patients with moderate or severe ischemia: secondary analysis of the ISCHEMIA randomized clinical trial","volume":"5","author":"Reynolds","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib158","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/eurheartj\/ehm617","article-title":"MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial","volume":"29","author":"Schwitter","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.02.001_bib159","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/eurheartj\/ehs022","volume":"34","author":"Schwitter","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.02.001_bib160","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/CIRCULATIONAHA.107.743963","article-title":"Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy","volume":"117","author":"Shaw","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib161","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s12350-012-9548-3","volume":"19","author":"Shaw","year":"2012","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib162","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.114.002666","article-title":"Diagnostic accuracy of stress myocardial perfusion imaging compared to invasive coronary angiography with fractional flow reserve meta-analysis","volume":"8","author":"Takx","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2025.02.001_bib163","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/CIRCULATIONAHA.114.011939","article-title":"Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization","volume":"131","author":"Taqueti","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib164","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jcmg.2017.02.006","article-title":"Stress perfusion CMR in patients with known and suspected CAD: prognostic value and optimal ischemic threshold for revascularization","volume":"10","author":"Vincenti","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2025.02.001_bib165","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jcin.2014.01.161","article-title":"Prognostic value of \"routine\" cardiac stress imaging 5 years after percutaneous coronary intervention: the prospective long-term observational BASKET (Basel Stent Kosteneffektivitats Trial) LATE IMAGING study","volume":"7","author":"Zellweger","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2025.02.001_bib166","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2967\/jnumed.107.046771","article-title":"Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation","volume":"49","author":"Zellweger","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib167","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jacc.2011.11.024","article-title":"Coronary artery disease progression late after successful stent implantation","volume":"59","author":"Zellweger","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib168","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.jacc.2021.07.053","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"78","author":"Gulati","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib169","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib170","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib171","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib172","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.02.001_bib173","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jacc.2022.07.006","article-title":"2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"80","author":"Lloyd-Jones","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib174","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/jamacardio.2019.2306","article-title":"Effect of simvastatin-ezetimibe compared with simvastatin monotherapy after acute coronary syndrome among patients 75 years or older: a secondary analysis of a randomized clinical trial","volume":"4","author":"Bach","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib175","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jacc.2016.11.070","article-title":"Atherothrombotic risk stratification and ezetimibe for secondary prevention","volume":"69","author":"Bohula","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib176","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S2213-8587(18)30290-0","article-title":"Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial","volume":"6","author":"Bonaca","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2025.02.001_bib177","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamacardio.2017.2289","article-title":"Simulation of lipid-lowering therapy intensification in a population with atherosclerotic cardiovascular disease","volume":"2","author":"Cannon","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib178","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1161\/CIRCULATIONAHA.117.028503","volume":"135","author":"Virani","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib179","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1701131","article-title":"Cognitive function in a randomized trial of evolocumab","volume":"377","author":"Giugliano","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.02.001_bib180","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jacc.2019.03.013","article-title":"Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES trial","volume":"74","author":"Jukema","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib181","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jamacardio.2019.0886","article-title":"Effect of the PCSK9 inhibitor evolocumab on total cardiovascular events in patients with cardiovascular disease: a prespecified analysis from the FOURIER Trial","volume":"4","author":"Murphy","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.02.001_bib182","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1161\/CIRCULATIONAHA.119.042551","article-title":"Risk categorization using new American College of Cardiology\/American Heart Association guidelines for cholesterol management and its relation to alirocumab treatment following acute coronary syndromes","volume":"140","author":"Roe","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib183","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/CIRCULATIONAHA.118.034309","article-title":"Clinical benefit of evolocumab by severity and extent of coronary artery disease: analysis from FOURIER","volume":"138","author":"Sabatine","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.02.001_bib184","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/phar.2635","article-title":"Meta-analysis of clinical outcomes of PCSK9 modulators in patients with established ASCVD","volume":"41","author":"Talasaz","year":"2021","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jacc.2025.02.001_bib185","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2213-8587(16)30156-5","article-title":"Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials","volume":"4","author":"Cholesterol Treatment Trialists' (CTT) Collaboration","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2025.02.001_bib186","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pec.2014.01.012","article-title":"A systematic review of patient education in cardiac patients: do they increase knowledge and promote health behavior change?","volume":"95","author":"Ghisi","year":"2014","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.jacc.2025.02.001_bib187","article-title":"Medication adherence interventions: comparative effectiveness. Closing the quality gap: revisiting the state of the science: executive summary","year":"2012","journal-title":"AHRQ"},{"key":"10.1016\/j.jacc.2025.02.001_bib188","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2147\/JMDH.S257273","article-title":"Impact of pharmacist-led interventions on medication adherence and clinical outcomes in patients with hypertension and hyperlipidemia: a scoping review of published literature","volume":"13","author":"Elnaem","year":"2020","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.jacc.2025.02.001_bib189","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12872-021-02178-0","article-title":"Effects of a pharmaceutical care intervention on clinical outcomes and patient adherence in coronary heart disease: the MIMeRiC randomized controlled trial","volume":"21","author":"Ostbring","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2025.02.001_bib190","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/eurheartj\/ehaa134","article-title":"Medicine and society: social determinants of health and cardiovascular disease","volume":"41","author":"Roger","year":"2020","journal-title":"Eur Heart J"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725002827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725002827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:35:56Z","timestamp":1782952556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109725002827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":188,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0735109725002827"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2025.02.001","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2025 AHA\/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2025.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Heart Association, Inc and American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}